This Solicitation opportunity from Department Of Defense was posted on June 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
LEVOFLOXACIN TABLET
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of Levofloxacin tablets, identified by the National Stock Number 6505-01-444-6632, under purchase request number 7017078604 for a quantity of one unit. The solicitation, titled "LEVOFLOXACIN TABLET" with solicitation number SPE2DP-26-T-3763, was posted on June 8, 2026, and responses were due by June 15, 2026. This is a federal solicitation issued by the Defense Logistics Agency, part of the Department of Defense, for the procurement of this pharmaceutical product. The contract does not specify any set-aside types or North American Industry Classification System (NAICS) codes, and no detailed place of performance or office address information is provided. The procurement is solely for federal use, with the relevant details accessible through the provided link to the Defense Logistics Agency's contracting system. This contract indicates the government’s intent to obtain a critical antibiotic tablet through a competitive solicitation process within a defined timeline.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
